Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- The Chilean Hachiko: puppy “Peluchín” is still waiting for his deceased owner in La Serena Nov 10, 2022
- Mercedes-AMG plug-in hybrid, features GT 63 SE Performance Sep 1, 2021
- The diplomat detained in St. Petersburg arrives at the Estonian consulate Jul 8, 2021
- They create a robot that looks like a cockroach and is capable of supporting a million times its own weight Jul 6, 2021
- “Yellow vests”: “We are here to keep the embers alive” … Four years later, they still hold a roundabout Nov 17, 2022
- Prime Video, “The Wheel of Time”: release date, trailer and plot Sep 3, 2021
- Gaby Spanic celebrated his legal victory against Gustavo Adolfo Infante: “He said so much barbarism about me” May 27, 2022